Carson Wealth (CWM LLC)
STLN

Carson Wealth (CWM LLC)’s Starling Oncology STLN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.12K Buy
1,992
+1,989
+66,300% +$6.1K ﹤0.01% 4957
2025
Q4 		$0 Sell
3
-106
-97% -$393 ﹤0.01% 5642
2025
Q3 		$0 Buy
+109
New +$373 ﹤0.01% 5551

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $413M AUM 109.83% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carson Wealth (CWM LLC)'s STLN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Starling Oncology (STLN) stake by 66,300% in Q1 2026, buying an estimated $6.1K and bringing the position to 1,992 shares worth $6.12K. The position accounts for ﹤0.01% of the portfolio, ranked #4957.

Carson Wealth (CWM LLC) first reported a position in STLN in Q3 2025 and has held it in 3 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,992 shares of Starling Oncology worth $6.12K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,989 Starling Oncology shares in Q1 2026, an estimated $6.1K.
  • Starling Oncology made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4957 holding.
  • Carson Wealth (CWM LLC) first reported a position in Starling Oncology in Q3 2025 and has held it in 3 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.